Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

QSample: An Automated System for Rapid Monitoring of Quality Indicators in Proteomics Samples.

Created on 19 Aug 2025

Authors

Roger Olivella, Cristina Chiva, Marc Serret, Antoni Hermoso, Eva Borràs, Guadalupe Espadas, Julia Morales-Sanfrutos, Olga Pastor, Amanda Solé, Julia Ponomarenko, Eduard Sabidó

Published in

Journal of proteome research. Aug 19, 2025. Epub Aug 19, 2025.

Abstract

Mass spectrometry-based proteomics is an essential technique in contemporary biomedicine, offering quantitative, sensitive, and rapid analysis of proteomes. Recent advancements in mass spectrometry have enabled the acquisition of data from increasingly large-scale experiments, often conducted in core facilities and research infrastructures. While automated tools exist to assess instrument performance using predefined control samples, the analysis of experimental samples typically occurs postacquisition, which can delay decision-making and lead to potential data integrity issues. To address these challenges, we developed QSample, an open-source automated system for rapidly monitoring quality indicators in proteomics samples during data collection. QSample enhances the quality control framework by facilitating prompt actions and fast decision-making, ensuring that proteomics core facilities deliver data that adhere to best research practices.

PMID:
40827108
Bibliographic data and abstract were imported from PubMed on 19 Aug 2025.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 52
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement